Surgicure Technologies, a Boston, MA-based company dedicated to advancing airway management and patient safety, raised $1.785M in Seed funding.
The round was led by Launchpad Venture Group (LVG) with major contributions form Gurtin Ventures, with participation from BakerBridge Capital, TiE Angels, SBXi, Beacon Angels, SideCar Angels, Tidal River Fund and BBE Ventures.
The company intends to use the funds to accelerate the commercialization of its flagship product, the Horseshoe™, designed to improve the quality and safety of patient care across diverse medical settings.
Founded in 2019 by Irena King, Surgicure Technologies is on a mission to reduce adverse events in airway management by introducing devices that optimize patient breathing and streamline clinical workflows. Originally invented by army respiratory therapists and now re-designed by King, the company’s flagship product, the Horseshoe, is a novel patented solution for more reliable ET tube securement, prevention of facial pressure injuries, and more effective oral care. This technology improves clinical outcomes and offers cost savings and device versatility in critical care, burn/trauma scenarios, and during evacuation or transport.
FinSMEs
12/03/2025